However, the relative effects of investigational mTOR active-site inhibitory drugs on tumor cell growth, production of vascular growth factors, versus direct effects on the host vasculature in in vivo mouse xenograft models are difficult to determine. This evidence concerns the gene MTOR and neoplasm.